These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32857728)

  • 1.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
    Lin BY; Wen JL; Zheng C; Lin LZ; Chen CZ; Qu JM
    J Cell Mol Med; 2020 Nov; 24(22):13070-13080. PubMed ID: 32969138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Chen CZ; Wen JL; Lin BY; Zheng C; Quan RD; Zhang XH; Qu JM
    Biomark Med; 2020 Jul; 14(11):969-980. PubMed ID: 32940082
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.
    You A; Fu L; Li Y; Li X; You B
    Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
    Ding Z; Ke R; Zhang Y; Fan Y; Fan J
    Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition
    Chen LL; Gao GX; Shen FX; Chen X; Gong XH; Wu WJ
    Mol Cells; 2018 Sep; 41(9):853-867. PubMed ID: 30165731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
    Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
    Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
    Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
    Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
    Zhao YL; Yuan BQ; Shen GS
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.
    Shao L; Sun W; Wang Z; Dong W; Qin Y
    IUBMB Life; 2020 Feb; 72(2):237-246. PubMed ID: 31478331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.